Oppenheimer Raises Apple's Price Target, Notes Significant Advantage Over All Device Platforms

In a note out Tuesday, Oppenheimer is raising its price target on Apple Inc. (NASDAQ: AAPL) from $115 to $130 and maintained its Outperform rating.

Key points from the research note:

  • Ecosystem: iPhone and iPad (to a lesser extent, Macbook) have matured and are able to cover the full range of user preference regarding size, power, portability, and feature sets. And with expected Spring launch of a watch, Apple has covered the past, present, and future of our needs for consumer-level human-machine interaction.

  • User Experience: Apple not only progressed to enable a more consistent user experience across its platforms (OS X and iOS), it is forming external partnerships to transfer an "Apple-like" user experience to other verticals (think Apple Pay in retail). We believe these partnerships have a far-reaching impact on Apple's ability to sustain its own devices sales.

  • Weaker Competition: We believe in the current product cycle, competitors are unlikely to provide compelling matching features to threaten Apple's major product categories.

  • Model Adjustments: We introduce our FY16 revenues/EPS of $229B/$8.58. Our FY15 revenues/EPS are raised from $208.7B/$7.36 to $220B/$7.80 based on higher iPhone shipment and ASP assumptions. Our new PT of $130 (from $115) is based on 14x FY15 EPS of $7.80 plus $21 per share net cash

Oppenheimer reiterated its Outperform rating on Apple for its renewed ecosystem, its significant advantage over any other device platforms, and near-term market share gain opportunities

Shares of Apple closed Monday at $113.99, implying roughly 10.5 percent upside to the $130 price target.

Latest Ratings for AAPL

Nov 2014

Oppenheimer

Maintains

Outperform

Oct 2014

Cantor Fitzgerald

Maintains

Buy

Oct 2014

Barclays

Maintains

Overweight

View More Analyst Ratings for AAPL
View the Latest Analyst Ratings

See more from Benzinga

© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement